Zai Lab Limited Peer Comparison
Metric | Value | Ranking | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $3.2 Billion | 12/15 | SGEN $43.2B |
ALNY $33.2B |
RXDX $9.6B |
ASND $8.6B |
ROIV $7.5B |
MDGL $7.4B |
LEGN $6.7B |
BPMC $6.0B |
KRYS $4.4B |
PTCT $4.0B |
APLS $3.4B |
ZLAB $3.2B |
ICPT $794.7M |
ERAS $443.9M |
CCCC $224.5M |
Gross Margin | 64% | 14/15 | ICPT 100% |
RXDX 100% |
ALNY 99% |
BPMC 98% |
MDGL 97% |
PTCT 92% |
ASND 92% |
KRYS 90% |
ROIV 88% |
CCCC 87% |
APLS 81% |
SGEN 75% |
LEGN 65% |
ZLAB 64% |
ERAS 0% |
Profit Margin | -41% | 9/15 | ROIV 100% |
KRYS 32% |
ERAS 0% |
ICPT -3% |
ASND -22% |
ALNY -27% |
SGEN -33% |
APLS -33% |
ZLAB -41% |
BPMC -44% |
LEGN -78% |
PTCT -79% |
MDGL -100% |
CCCC -100% |
RXDX -100% |
EBITDA margin | -37% | 7/15 | KRYS 27% |
ICPT -3% |
ALNY -18% |
ASND -22% |
BPMC -26% |
SGEN -34% |
ZLAB -37% |
APLS -38% |
PTCT -40% |
LEGN -69% |
ERAS -100% |
MDGL -166% |
CCCC -184% |
ROIV -409% |
RXDX -4408% |
Quarterly Revenue | $102.3 Million | 8/15 | SGEN $648.7M |
ALNY $420.1M |
ASND $191.1M |
APLS $176.6M |
LEGN $160.2M |
PTCT $135.4M |
BPMC $128.2M |
ZLAB $102.3M |
ICPT $88.8M |
KRYS $83.8M |
MDGL $62.2M |
ROIV $55.1M |
CCCC $15.4M |
RXDX $1.1M |
ERAS $0 |
Quarterly Earnings | -$41.7 Million | 7/15 | ROIV $95.3M |
KRYS $27.2M |
ICPT -$2.8M |
CCCC -$24.7M |
ERAS -$31.2M |
RXDX -$33.0M |
ZLAB -$41.7M |
ASND -$42.3M |
BPMC -$56.3M |
APLS -$57.4M |
PTCT -$106.7M |
MDGL -$107.0M |
ALNY -$111.6M |
LEGN -$125.3M |
SGEN -$215.8M |
Quarterly Free Cash Flow | -$56.7 Million | 10/15 | KRYS $57.8M |
ALNY $39.5M |
APLS $34.1M |
ICPT $3.9M |
BPMC -$13.7M |
ERAS -$22.4M |
PTCT -$22.8M |
CCCC -$24.1M |
RXDX -$40.1M |
ZLAB -$56.7M |
MDGL -$62.8M |
LEGN -$77.9M |
SGEN -$79.8M |
ASND -$96.2M |
ROIV -$193.8M |
Trailing 4 Quarters Revenue | $355.7 Million | 8/15 | SGEN $2.3B |
ALNY $2.0B |
PTCT $839.3M |
APLS $675.9M |
LEGN $520.2M |
BPMC $434.4M |
ASND $399.8M |
ZLAB $355.7M |
ICPT $317.7M |
KRYS $241.5M |
ROIV $158.3M |
MDGL $76.8M |
CCCC $33.7M |
RXDX $4.0M |
ERAS $0 |
Trailing 4 Quarters Earnings | -$270.8 Million | 9/15 | SGEN $648.7M |
ALNY $420.1M |
ASND $191.1M |
APLS $176.6M |
LEGN $160.2M |
PTCT $135.4M |
BPMC $128.2M |
ZLAB $102.3M |
ICPT $88.8M |
KRYS $83.8M |
MDGL $62.2M |
ROIV $55.1M |
CCCC $15.4M |
RXDX $1.1M |
ERAS -$0 |
Quarterly Earnings Growth | 40% | 6/15 | KRYS 182% |
ROIV 133% |
APLS 59% |
BPMC 58% |
ASND 56% |
ZLAB 40% |
CCCC 31% |
PTCT 20% |
RXDX -3% |
ERAS -3% |
MDGL -8% |
SGEN -13% |
ICPT -101% |
LEGN -101% |
ALNY -176% |
Annual Earnings Growth | 37% | 8/15 | ROIV 679% |
KRYS 133% |
BPMC 76% |
ALNY 51% |
APLS 51% |
LEGN 47% |
PTCT 38% |
ZLAB 37% |
ASND 34% |
CCCC 23% |
RXDX -15% |
SGEN -26% |
ERAS -27% |
MDGL -46% |
ICPT -124% |
Quarterly Revenue Growth | 48% | 5/15 | ROIV 155% |
BPMC 127% |
APLS 78% |
LEGN 67% |
ZLAB 48% |
SGEN 27% |
ASND 26% |
ICPT 14% |
MDGL 0% |
KRYS 0% |
CCCC 0% |
ERAS 0% |
PTCT -31% |
ALNY -44% |
RXDX -72% |
Annual Revenue Growth | 29% | 7/15 | CCCC 199% |
BPMC 89% |
APLS 76% |
LEGN 65% |
ROIV 53% |
RXDX 32% |
ZLAB 29% |
ASND 29% |
ALNY 18% |
SGEN 15% |
ICPT 8% |
MDGL 0% |
PTCT 0% |
KRYS 0% |
ERAS 0% |
Cash On Hand | $616.1 Million | 3/15 | ROIV $5.7B |
ALNY $1.1B |
ZLAB $616.1M |
ASND $614.9M |
PTCT $526.0M |
LEGN $459.3M |
SGEN $428.6M |
APLS $396.9M |
KRYS $374.0M |
MDGL $232.7M |
RXDX $113.3M |
ICPT $102.7M |
BPMC $89.4M |
ERAS $68.9M |
CCCC $59.6M |
Short Term Debt | $119.6 Million | 2/15 | ASND $540.1M |
ZLAB $119.6M |
BPMC $45.0M |
ALNY $42.1M |
ROIV $21.5M |
PTCT $16.8M |
APLS $6.8M |
CCCC $5.6M |
ERAS $4.5M |
LEGN $4.3M |
RXDX $3.5M |
KRYS $1.3M |
MDGL $878,000 |
SGEN -$0 |
ICPT -$0 |
Long Term Debt | $6.1 Million | 14/15 | ALNY $1.3B |
ASND $401.2M |
PTCT $383.5M |
LEGN $342.2M |
BPMC $341.5M |
ROIV $311.7M |
ICPT $223.9M |
MDGL $118.3M |
SGEN $113.5M |
APLS $104.7M |
CCCC $61.5M |
ERAS $48.5M |
RXDX $26.0M |
ZLAB $6.1M |
KRYS $0 |
PE | -1.00 | 3/15 | KRYS 84.15 |
ROIV 1.59 |
ZLAB -1.00 |
ALNY -1.00 |
SGEN -1.00 |
ICPT -1.00 |
MDGL -1.00 |
PTCT -1.00 |
BPMC -1.00 |
APLS -1.00 |
ASND -1.00 |
LEGN -1.00 |
CCCC -1.00 |
RXDX -1.00 |
ERAS -1.00 |
PS | 8.88 | 10/15 | RXDX 2392.62 |
MDGL 95.75 |
ROIV 47.60 |
ASND 19.63 |
SGEN 18.76 |
KRYS 18.25 |
ALNY 16.48 |
BPMC 13.82 |
LEGN 12.84 |
ZLAB 8.88 |
CCCC 6.67 |
APLS 5.04 |
PTCT 4.76 |
ICPT 2.50 |
ERAS -1.00 |
PB | 4.73 | 10/15 | ALNY 1026.12 |
BPMC 19.17 |
SGEN 16.92 |
APLS 14.37 |
RXDX 13.70 |
ICPT 11.06 |
MDGL 9.46 |
LEGN 5.99 |
KRYS 4.98 |
ZLAB 4.73 |
ROIV 1.28 |
ERAS 0.99 |
CCCC 0.93 |
PTCT 0.00 |
ASND 0.00 |
PC | 5.13 | 13/15 | SGEN 100.70 |
RXDX 84.33 |
BPMC 67.18 |
MDGL 31.61 |
ALNY 30.18 |
LEGN 14.55 |
ASND 14.02 |
KRYS 11.79 |
APLS 8.59 |
ICPT 7.74 |
PTCT 7.60 |
ERAS 6.44 |
ZLAB 5.13 |
CCCC 3.76 |
ROIV 1.33 |
Liabilities to Equity | 0.48 | 7/15 | ALNY 128.97 |
ICPT 4.47 |
BPMC 2.83 |
APLS 2.80 |
LEGN 0.56 |
CCCC 0.55 |
ZLAB 0.48 |
SGEN 0.42 |
MDGL 0.38 |
ERAS 0.18 |
KRYS 0.11 |
ROIV 0.11 |
RXDX 0.09 |
PTCT 0.00 |
ASND 0.00 |
ROA | -0.27 | 10/15 | ROIV 73% | KRYS 5% | ALNY -8% | BPMC -11% | ICPT -15% | RXDX -19% | LEGN -20% | SGEN -21% | PTCT -25% | ZLAB -27% | APLS -28% | CCCC -28% | ERAS -30% | ASND -35% | MDGL -48% |
ROE | -0.41 | 9/15 | ASND 394% |
ROIV 87% |
PTCT 43% |
KRYS 6% |
RXDX -20% |
SGEN -29% |
LEGN -31% |
ERAS -35% |
ZLAB -41% |
BPMC -41% |
CCCC -43% |
MDGL -67% |
ICPT -82% |
APLS -105% |
ALNY -1027% |
Current Ratio | 3.10 | 7/15 | RXDX 12.47 |
ROIV 10.81 |
KRYS 10.18 |
ERAS 6.71 |
MDGL 3.62 |
SGEN 3.35 |
ZLAB 3.10 |
CCCC 2.82 |
LEGN 2.80 |
APLS 1.36 |
BPMC 1.35 |
ICPT 1.22 |
ALNY 1.01 |
ASND 0.92 |
PTCT 0.64 |
Quick Ratio | 1.94 | 7/15 | KRYS 84.15 |
ROIV 1.59 |
ZLAB -1.00 |
ALNY -1.00 |
SGEN -1.00 |
ICPT -1.00 |
MDGL -1.00 |
PTCT -1.00 |
BPMC -1.00 |
APLS -1.00 |
ASND -1.00 |
LEGN -1.00 |
CCCC -1.00 |
RXDX -1.00 |
ERAS -1.00 |
Long Term Debt to Equity | 0.01 | 12/15 | ALNY} 38.93 |
ICPT} 3.12 |
BPMC} 1.09 |
APLS} 0.44 |
LEGN} 0.31 |
CCCC} 0.25 |
MDGL} 0.15 |
ERAS} 0.11 |
ROIV} 0.06 |
SGEN} 0.04 |
RXDX} 0.04 |
ZLAB} 0.01 |
KRYS} 0.00 |
PTCT} -0.36 |
ASND} -3.45 |
Debt to Equity | 0.19 | 7/15 | ALNY 40.24 |
ICPT 3.12 |
BPMC 1.23 |
APLS 0.47 |
LEGN 0.31 |
CCCC 0.28 |
ZLAB 0.19 |
ERAS 0.12 |
ROIV 0.07 |
SGEN 0.04 |
RXDX 0.04 |
MDGL 0.00 |
KRYS 0.00 |
PTCT -0.38 |
ASND -8.10 |
Burn Rate | 8.58 | 2/15 | ICPT 8.75 |
ZLAB 8.58 |
ALNY 6.38 |
APLS 6.27 |
PTCT 4.17 |
LEGN 3.28 |
RXDX 3.24 |
ASND 3.11 |
CCCC 2.09 |
MDGL 2.08 |
ERAS 2.01 |
SGEN 1.95 |
BPMC 1.10 |
KRYS -13.92 |
ROIV -73.38 |
Cash to Cap | 0.20 | 3/15 | ROIV 0.75 |
CCCC 0.27 |
ZLAB 0.20 |
ERAS 0.16 |
ICPT 0.13 |
PTCT 0.13 |
APLS 0.12 |
KRYS 0.08 |
ASND 0.07 |
LEGN 0.07 |
ALNY 0.03 |
MDGL 0.03 |
SGEN 0.01 |
BPMC 0.01 |
RXDX 0.01 |
CCR | 1.36 | 3/15 | ASND 2.28 |
KRYS 2.13 |
ZLAB 1.36 |
RXDX 1.21 |
CCCC 0.98 |
ERAS 0.72 |
LEGN 0.62 |
MDGL 0.59 |
SGEN 0.37 |
BPMC 0.24 |
PTCT 0.21 |
ALNY -0.35 |
APLS -0.59 |
ICPT -1.38 |
ROIV -2.03 |
EV to EBITDA | -70.13 | 8/15 | KRYS} 179.85 |
ERAS} -1.00 |
CCCC} -8.21 |
ROIV} -9.88 |
APLS} -46.24 |
LEGN} -59.76 |
MDGL} -69.16 |
ZLAB} -70.13 |
PTCT} -71.01 |
BPMC} -188.79 |
SGEN} -191.83 |
RXDX} -194.54 |
ASND} -257.89 |
ICPT} -331.82 |
ALNY} -434.32 |
EV to Revenue | 7.50 | 10/15 | RXDX 2371.62 |
MDGL 92.73 |
ASND 24.44 |
SGEN 18.62 |
KRYS 16.71 |
ALNY 16.58 |
BPMC 14.50 |
ROIV 14.09 |
LEGN 12.63 |
ZLAB 7.50 |
CCCC 6.89 |
APLS 4.62 |
PTCT 4.61 |
ICPT 2.88 |
ERAS -1.00 |